Market research from industry commentator GlobalData finds that new creams and tablets are on the way in plaque psoriasis (PsO) creams. 9 December 2021
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and the European Medicines Agency 30 November 2021
The Institute for Clinical and Economic Review (ICER) regularly calls out drugmakers in certain therapy areas for introducing drugs to the market at prices that 16 November 2021
US biotech company Regeneron Pharmaceuticals (Nasdaq: REGN) reported a 51% increase in its third-quarter revenue when announcing its latest financial results on 5 November 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.